Skip to main content
Jason Fangusaro, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

JasonRonaldFangusaroMD

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Neuro-Oncology

Director of Developmental Therapeutics Professor of Pediatrics Emory University School of Medicine, Aflac Cancer Center and the Children's Healthcare of Atlanta

Dr. Fangusaro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fangusaro's full profile

Already have an account?

Summary

  • Dr. Fangusaro has an expertise and specialty training in treating children with central nervous system malignancies, including brain and spinal cord tumors. His primary area of research interest is in the development of clinical trials, novel therapeutics and relevant biologic correlates in pediatric brain tumors in an effort to improve survival outcomes and minimize toxicities. He devotes much of his time to clinical trial research within the Children's Oncology Group (COG), the Pediatric Brain Tumor Consortium (PBTC) and with industry. His main areas of expertise, research and interest within CNS tumors include CNS Germ Cell Tumors, CNS Low Grade Glioma and Early Phase Clinical Trial development.

Education & Training

  • Children's Hospital of Los Angeles
    Children's Hospital of Los AngelesFellowship, Pediatric Neuro-Oncology, 2005 - 2006
  • Nationwide Children's Hospital/Ohio State University
    Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2002 - 2005
  • Advocate Health Care (Advocate Children's Hospital/Park Ridge)
    Advocate Health Care (Advocate Children's Hospital/Park Ridge)Residency, Pediatrics, 1999 - 2002
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1999
  • Loyola University of Chicago
    Loyola University of ChicagoB.A., Theatre Arts, 1991 - 1995

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2018 - 2023
  • CA State Medical License
    CA State Medical License 2005 - Present
  • OH State Medical License
    OH State Medical License 2001 - 2007
  • IL State Medical License
    IL State Medical License 1999 - 2020
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prospective Feasibility and Safety of Surgical Biopsy for Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma  
    Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Ge..., Neuro Oncol, 1/5/2018
  • Phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC)  
    Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S..., Neuro Oncol, 1/28/2017
  • Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival  
    Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al- Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, Fang..., 1/21/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Outcomes of a Phase 2 trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System (CNS) Non-Germinomatous Germ Cell Tumors NGGCT): a C...
    Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, Khatua S, Boyett J, Williams-Hughes C, Souweidane M, Lu H, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M..., Neuro-Oncology, 1/1/2018
  • A Phase II and Re-treatment Study of Selumetinib in Children with Recurrent/Progressive LGG: a Pediatric Brain Tumor Consortium Study
    Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn L, Pollack IF, Qaddoumi I, Fisher PG, Dhall G, Baxter P, Kreissman..., Neuro-Oncology, 1/1/2018
  • A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG: A Pediatric Brain Tumor Consortium Study
    Fangusaro J,� Onar-Thomas A,� Young-Poussaint T,�Wu S, Ligon AH, Lindeman NI, Banerjee A,�Packer R,�Kilburn LB,�Pollack I,�Jakacki R,�Qaddoumi IA, Fisher PG, Dhall G,�..., Journal of Clini Oncology, 1/1/2017
  • Join now to see all

Lectures

  • A phase II clinical study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Targeting MAPK in Pediatric Oncology 
    Chicago, IL - 1/1/2018
  • MEK Inhibition in Patients with Newly Diagnosed NF Associated LGG, A COG Trial Concept Update 
    Denver, CO - 1/1/2018
  • Join now to see all

Other

Press Mentions

  • Activity of Selumetinib in Pediatric Pilocytic Astrocytoma and Low-Grade Glioma
    Activity of Selumetinib in Pediatric Pilocytic Astrocytoma and Low-Grade GliomaJune 6th, 2019
  • Northwestern Medicine Experts Available to Speak on Presentations at the 2017 ASCO Annual Meeting
    Northwestern Medicine Experts Available to Speak on Presentations at the 2017 ASCO Annual MeetingMay 30th, 2017
  • Contents
    ContentsFebruary 12th, 2021
  • Join now to see all

Committees

  • Co-leader, International Coalition on Pediatric LGG 2020 - Present
  • Chair, RAPNO LGG International Committee 2018 - Present
  • Member, COG CNS Steering Committee 2017 - Present
  • Vice-Chair, PBTC Executice Committee 2016 - Present
  • Member, International CNS GCT Committee 2013 - Present
  • Member, COG CNS Committee 2010 - Present

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

Industry Relationships

  • Pediatric Advisory Board, Celgene2016 - 2020